US$ 21.39
innoviva glp-1 receptor agonist weight management diabetes treatments agonists How to use GLP-1 receptor
Description
Sciences 2023 Breakthrough: GLP-1R Agonists 2024-08-13 Rapid increase in obesity rate is becoming a global public health crisis [1]

The molecule does not change, but its economic status does

Although there is no data in humans, GLP-1RAs should not be used in patients with a past or family history of medullary thyroid cancer or in patients with multiple endocrine neoplasia type 2

Zero human studies

Lancet 372, 12401250

Collectively, the findings from these preclinical studies provide compelling evidence that GLP-1RAs modulate nicotine-related behaviors through both mesolimbic and habenulabrainstem pathways
